Quantum Cyber N.V. issues $6M preferred shares; David Lazar gains >95% voting control and Co-CEO resigns

Quantum Cyber N.V.

Second closing on Apr 22, 2026: issued Series D/E preferred convertible into up to 225M ordinary shares each, representing >90% fully diluted shares.
David Lazar becomes controlling shareholder with >95% voting rights; four directors and Co-CEO Guido Baechler resigned; David Natan and Avraham Ben-Tzvi appointed.
Name changed from Mainz Biomed N.V. to Quantum Cyber N.V.; authorized ordinary shares increased from 45M to 900M, preferred from 5M to 100M.
All 11 proposals approved at Apr 22 Extraordinary General Meeting, including ratification of board appointments and share issuance.

item 1.01item 3.02item 5.01item 5.02item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.